Traditional Chinese medicine preparation for treating tuberculous pleuritis

Abstract

The invention discloses a traditional Chinese medicine preparation for treating tuberculous pleuritis. The traditional Chinese medicine preparation for treating tuberculous pleuritis disclosed by the invention is prepared from the following traditional Chinese medicines in parts by weight: 10-15 parts of frangrant ainsliaea herb, 10-18 parts of aletris spicata, 5-10 parts of galangal, 3-5 parts of alpinia oxyphylla, 15-22 parts of ardisia japonica, 10-18 parts of przewalskii, 12-18 parts of arisaema asperatum, 15-20 parts of radix asparagi, 5-8 parts of amur barberry root, 4-8 parts of rhizoma bletillae genus, 8-15 parts of boerhavia diffusa, 10-12 parts of brachystelma edule, 2-4 parts of buddleja asiatica and 3-8 parts of codonopsis lancifolia. According to dialectical theories of traditional Chinese medicines, the traditional Chinese medicine preparation for treating tuberculous pleuritis disclosed by the invention has the benefits that the formula is simple, materials are easily available, cost is low, the curative effect is high and no any toxic or side effect is caused. The traditional Chinese medicine preparation has the effects of regulating the flow of vital energy, dredging collaterals, reducing phlegm, invigorating the circulation of blood, nourishing yin and clearing heat; and therefore, the traditional Chinese medicine preparation for treating tuberculous pleuritis disclosed by the invention has curative effects for all patients and has broad-spectrum practicability.

Description

technical field [0001] The invention belongs to a traditional Chinese medicine, in particular to a traditional Chinese medicine preparation for treating tuberculous pleurisy. Background technique [0002] Tuberculosis is a chronic consumptive infectious disease caused by Mycobacterium tuberculosis, with the highest incidence among young people. Tuberculosis is a common disease that seriously endangers people's health. According to statistics, about 1.7 billion people are infected with tuberculosis in the world, and 3 million people die every year. Some people will Tuberculosis is called a "second cancer". [0003] Among them, tuberculous pleurisy is a common clinical tuberculosis. The disease has a long course and complicated condition. Generally, traditional treatment takes a long time. 92% of the deaths due to tuberculosis are found to be complicated with pleural lesions. Pleurisy, in recent years, the refractory and primary drug-resistant tuberculosis caused by irregular...

AI Technical Summary

Problems solved by technology

[0003] Among them, tuberculous pleurisy is a common clinical tuberculosis. The disease has a long course and complicated condition. Generally, traditional treatment takes a long time. 92% of the deaths due to tuberculosis are found to be complicated with pleural lesions. Pleurisy, in recent years, the refractory and primary drug-resistant tuberculosis caused by irregular drug use has gradually increased. In the treatment of tuberculous pleurisy, people are mostly looking for efficient, safe and alternative anti-tuberculosis drugs. Such as intrathoracic short-term injection of hormones, anti-tuberculosis drugs and vasodilators, external application of traditional Chinese medicine ointment, etc., but these treatment methods have problems of unsatisfactory curative effect and serious side effects

Images